AR and neoplasm: While the induction of AR-specific immune responses may be more challenging in patients due to elevated immune tolerance in the tumor microenvironment, immunity against splice variant cryptic epitopes may be more easily achieved considering that protein expression of these epitopes is undetectable in benign tissues, which may signify a lower level of central immune tolerance against these epitopes.